# A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)

> **NCT00109564** · PHASE2 · COMPLETED · sponsor: **Targacept Inc.** · enrollment: 174 (—)

## Conditions studied

- Age-Related Memory Disorders

## Interventions

- **DRUG:** ispronicline (nicotinic acetylcholine receptor agonist)

## Key facts

- **NCT ID:** NCT00109564
- **Lead sponsor:** Targacept Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** 174 (—)
- **Last updated:** 2008-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00109564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00109564, "A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00109564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*